MOLECULAR EXPRESS, INC.

Company Information

Company Name
MOLECULAR EXPRESS, INC.
Address
2011 E University Drive
RANCHO DOMINGUEZ, CA, 90220-6411
Phone
n/a
URL
n/a
DUNS
58878682
Number of Employees
n/a
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$7,921,128.00
23
SBIR Phase II
$6,884,802.00
4
STTR Phase I
$843,313.00
3

Award List

  1. LIPOSOMAL VACCINE ADJUVANT FOR INFLUENZA IMMUNIZATION

    Amount: $100,000.00

    Not Available This effort proposes a true innovation in the combined areas of missile guidance and ordnance fuzing that will lead to the development of a single imaging detector array with the capabi ...

    SBIR Phase I 1999 Department of Health and Human Services
  2. N/A

    Amount: $100,000.00

    N/A

    SBIR Phase I 2000 Department of Health and Human Services
  3. TARGETED LIPOSOMAL DRUG DELIVERY TO LEUKEMIA CELLS

    Amount: $156,850.00

    DESCRIPTION: (Applicant's Description) The principal objective of this research plan is to design a targeted drug delivery system for specific r ...

    SBIR Phase I 2001 Department of Health and Human Services
  4. RAPID VACCINE DEVELOPMENT SYSTEM

    Amount: $131,960.00

    DESCRIPTION (provided by applicant): Bioterrorism has not received serious attention until recently. That view has changed, however, since the possibility of a biological weapon being deployed agains ...

    SBIR Phase I 2002 Department of Health and Human Services
  5. Universal Influenza Matrix 2 Subunit Vaccine

    Amount: $885,995.00

    DESCRIPTION (provided by applicant): Bioterrorism has recently been elevated as a major concern as both military and civilian populations have been targeted for attack with anthrax spores through the ...

    SBIR Phase I 2003 Department of Health and Human Services
  6. Development of liposomal fenretinide and safingol

    Amount: $496,120.00

    DESCRIPTION (provided by applicant): The principal objective of this research plan is to evaluate the effectiveness of the combination use of liposomal encapsulated fenretinide and safingol for the ...

    SBIR Phase I 2003 Department of Health and Human Services
  7. Repair, Regeneration, and Differentiation in Humans

    Amount: $729,997.00

    Although improvements in body armor have had a significant impact on reducing mortality in soldiers, ballistic damage to appendages such as arms and legs often results in loss of function or loss of t ...

    SBIR Phase II 2005 ArmyDepartment of Defense
  8. Repair, Regeneration, and Differentiation in Humans

    Amount: $119,976.00

    Although improvements in body armor have had a significant impact on reducing mortality in soldiers, ballistic damage to appendages such as arms and legs often results in loss of function or loss of t ...

    SBIR Phase I 2005 ArmyDepartment of Defense
  9. Production of a Lung Surfactant SP-B Mimic

    Amount: $138,000.00

    DESCRIPTION (provided by applicant): Surfactant Protein B (SP-B) is important for the normal functioning of lung surfactant. Using the known three-dimensional structures of proteins which also belong ...

    SBIR Phase I 2005 Department of Health and Human Services
  10. LIPOSOME-BASED VACCINE ADJUVANT SYSTEM FOR HIV

    Amount: $99,560.00

    N/A

    SBIR Phase I 1998 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government